Cristian Moreno – Managing Director – Torque Metals (ASX:TOR) is an exploration company with a proven discovery methodology, combining drilling results with machine learning algorithms and geological interpretation.
Copyright 2024 – Finance News Network
25 Jul 2024 - Alex Dorsch - CEO & Managing Director - Chalice Mining (ASX:CHN) is advancing the Gonneville Project—a major 2020 discovery in Western Australia with critical metals like platinum, nickel, and copper—towards development. The project boasts a tier-1 Mineral Resource Estimate, significant land in the new West Yilgarn Ni-Cu-PGE Province, and has earned multiple awards, including the 2023 Thayer Lindsley Award.
22 Nov 2023 - Jonathan Fisher serves as the CEO of Cauldron Energy (ASX:CXU). Cauldron Energy is primarily engaged in exploration activities, with a specific focus on uranium and critical minerals in the Western Australia region.
09 Sep 2020 - BrainChip Holdings Limited (ASX:BRN) President & CEO Louis DiNardo provides an update on collaboration and partnerships for the company's AI chip, Akida.
06 Jul 2023 - Tamboran Resources Limited (ASX:TBN) Managing Director and CEO Joel Riddle discusses the company's recent capital raise, the drilling timeline, and agreements with APA Group, Clean Energy Fuels Australia, BP and Shell.
01 Dec 2021 - MinRex Resources Limited (ASX:MRR) Non-Executive Director George Karageorge provides an update on the company's gold and base metals projects in WA and the Lachlan Ford Belt, NSW and its recently acquired lithium projects in the Pilbara.
19 May 2023 - CODA Minerals Limited (ASX:COD) CEO and Executive Director Chris Stevens provides an overview of the company, discussing early successes, scoping study results and timeline.
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
20 Sep 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the FDA's award of orphan status and rare paediatric disease designation for the company's DUNP19 technology.